A study of over 99 million people    (7/10)

The study was conducted by the   Global Vaccine Data Network   on over 99 million people. The project focused on eight countries (Argentina, Australia, Canada, France, Denmark, Finland, New Zealand, and Scotland), and the results were published in the journal   Vaccine  .

The words of the researchers   (8/10)

“Most of those vaccinated were between the ages of 20 and 59, and   the largest number of doses were administered in France  ,” the researchers explained, specifying that the vaccines came from Pfizer, Moderna, and AstraZeneca. The results did not reassure healthcare workers, much less patients.

Researchers observed an increase in cases of Guillain-Barré syndrome and cerebral venous thrombosis after the first dose of the AstraZeneca vaccine. Guillain-Barré syndrome is primarily characterized by muscle weakness, while venous thrombosis is the formation of a blood clot in a vein, obstructing blood flow throughout the body. French NBA star Victor Wembanyama suffered from the latter condition a few months ago, forcing him to interrupt his season.

Additionally, all vaccines significantly increased the risk of myocarditis and pericarditis (inflammation of the myocardium, the muscle responsible for heart contraction and blood circulation throughout the body)   . ”  Other warning signs have been identified that require further investigation  ,” the journal states. The researchers emphasize that further research is needed to determine the link between the vaccine and these side effects.

Given the alarming situation, COVID-19 vaccines were urgently developed. After nearly five years of observation and analysis, we now know the side effects of the various vaccines we have received.